Baozun Releases 2024 Sustainability Report
SHANGHAI, April 23, 2025 /PRNewswire/ — Baozun Inc. (Nasdaq: BZUN and HKEX: 9991) (“Baozun”, “we” or the “Company”), a... Read more.
Funnel’s Forum draws 12% of all professionally managed apartment representatives, attendance up 40% from inaugural event
Major AI announcements—Sierra-powered chat goes live, resident AI launches, Insights call-scoring now free—paired with thought leadership from Ryan Holiday,... Read more.
Ashcroft Capital Announces Acquisition of Birchstone Waterleigh
Orlando-Area Class-A Community Features 300 Apartment Homes NEW YORK, April 23, 2025 /PRNewswire/ — Ashcroft Capital, a fully integrated multifamily investment... Read more.
Vaulted Deep Wins $8M in XPRIZE Carbon Removal Competition
Company named second runner-up for safe, geologic disposal of organic waste with durable carbon storage HOUSTON, April 23, 2025 /PRNewswire/ — Vaulted Deep,... Read more.
TrueBlue and OMNIA Partners Announce Strategic Partnership to Deliver Smart Workforce Solutions
Partnership Helps Private Sector Source Optimized Talent Strategies to Drive Cost Savings and Operational Efficiency TACOMA, Wash., April 23, 2025 /PRNewswire/ — TrueBlue... Read more.
Efemoral Medical Releases Positive Long-Term Results from EFEMORAL I
Initial 20 Patients Enrolled in the First-in-Human Trial Had a 0% Rate of Reintervention. LOS ALTOS, Calif., April 23, 2025 /PRNewswire/ — The initial long-term... Read more.
MONEYTHUMB’S THUMBPRINT® SECURES PATENT FOR FRAUD DETECTION TECHNOLOGY IN DOCUMENT AUTHENTICATION
Patented Technology Tackles Rampant Fraud in Loan Applications, Helping to Reduce Losses and Increase Revenue SAN DIEGO, April 23, 2025 /PRNewswire/ —... Read more.
WebMD Ignite Launches Enhancements to Coach to Improve Health Plan Member Engagement and Reduce Costs
New capabilities enable faster, more efficient outreach for health plan care managers to help members take control of their health and reduce downstream costs NEWARK,... Read more.
Adcendo ApS to Present Data on its Clinical Stage ADCs ADCE-T02 and ADCE-D01 at the 2025 American Association for Cancer Research (AACR) Annual Meeting
ADCE-T02 – a potential first and best-in-class topoisomerase-1 (Topo-1) inhibitor-based Antibody-Drug Conjugate (ADC) against Tissue Factor – demonstrates... Read more.
Labcorp Launches Molecular Residual Disease and Liquid Biopsy Solutions
Labcorp® Plasma Detect™ now available for clinical use to assess risk of recurrence in stage III colon cancer patients FDA-authorized liquid biopsy assay PGDx... Read more.